403 related articles for article (PubMed ID: 26206523)
1. Role of organic cation transporters in drug-drug interaction.
Koepsell H
Expert Opin Drug Metab Toxicol; 2015; 11(10):1619-33. PubMed ID: 26206523
[TBL] [Abstract][Full Text] [Related]
2. Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced
Koepsell H
Expert Opin Drug Metab Toxicol; 2021 Jun; 17(6):635-653. PubMed ID: 33896325
[No Abstract] [Full Text] [Related]
3. Organic Cation Transporters in Health and Disease.
Koepsell H
Pharmacol Rev; 2020 Jan; 72(1):253-319. PubMed ID: 31852803
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Nies AT; Hofmann U; Resch C; Schaeffeler E; Rius M; Schwab M
PLoS One; 2011; 6(7):e22163. PubMed ID: 21779389
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the organic cation transporters (OCTs) in human airway pulmonary epithelial cells.
Ingoglia F; Visigalli R; Rotoli BM; Barilli A; Riccardi B; Puccini P; Dall'Asta V
Biochim Biophys Acta; 2015 Jul; 1848(7):1563-72. PubMed ID: 25883089
[TBL] [Abstract][Full Text] [Related]
6. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
7. Polyspecific organic cation transporters and their biomedical relevance in kidney.
Koepsell H
Curr Opin Nephrol Hypertens; 2013 Sep; 22(5):533-8. PubMed ID: 23852330
[TBL] [Abstract][Full Text] [Related]
8. Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics.
Wagner DJ; Hu T; Wang J
Pharmacol Res; 2016 Sep; 111():237-246. PubMed ID: 27317943
[TBL] [Abstract][Full Text] [Related]
9. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.
Nies AT; Koepsell H; Damme K; Schwab M
Handb Exp Pharmacol; 2011; (201):105-67. PubMed ID: 21103969
[TBL] [Abstract][Full Text] [Related]
10. Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection.
Jung N; Lehmann C; Rubbert A; Knispel M; Hartmann P; van Lunzen J; Stellbrink HJ; Faetkenheuer G; Taubert D
Drug Metab Dispos; 2008 Aug; 36(8):1616-23. PubMed ID: 18490433
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective Inhibition of High- and Low-Affinity Organic Cation Transporters.
Gebauer L; Jensen O; Rafehi M; Brockmöller J
Mol Pharm; 2023 Dec; 20(12):6289-6300. PubMed ID: 37962560
[TBL] [Abstract][Full Text] [Related]
12. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
13. In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions.
Kindla J; Fromm MF; König J
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):489-500. PubMed ID: 19416085
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in organic cation transporters and considerations in drug development.
Varma MVS
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):149-164. PubMed ID: 37070463
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for membrane transport of metformin in human intestinal epithelial Caco-2 cells.
Horie A; Sakata J; Nishimura M; Ishida K; Taguchi M; Hashimoto Y
Biopharm Drug Dispos; 2011 Jul; 32(5):253-60. PubMed ID: 21567399
[TBL] [Abstract][Full Text] [Related]
16. Stereoselectivity in Cell Uptake by SLC22 Organic Cation Transporters 1, 2, and 3.
Gebauer L; Jensen O; Rafehi M; Brockmöller J
J Med Chem; 2023 Dec; 66(23):15990-16001. PubMed ID: 38052451
[TBL] [Abstract][Full Text] [Related]
17. Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin.
Choi MK; Jin QR; Jin HE; Shim CK; Cho DY; Shin JG; Song IS
Biopharm Drug Dispos; 2007 Dec; 28(9):501-10. PubMed ID: 17876861
[TBL] [Abstract][Full Text] [Related]
18. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
[TBL] [Abstract][Full Text] [Related]
19. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.
Kimura N; Masuda S; Tanihara Y; Ueo H; Okuda M; Katsura T; Inui K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):379-86. PubMed ID: 16272756
[TBL] [Abstract][Full Text] [Related]
20. Genetic and Epigenetic Regulation of Organic Cation Transporters.
Kölz C; Schaeffeler E; Schwab M; Nies AT
Handb Exp Pharmacol; 2021; 266():81-100. PubMed ID: 33674913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
